Biopharmaceutical Products and Therapies

Impact of Bispecific and Trispecific Antibodies on the Treatment of Blood Cancers

Bispecific antibodies have transformed the treatment of relapsed or refractory Bcell lymphomas and multiple myeloma

How Misaligned Pharma and Diagnostic Timelines Are Slowing Targeted Therapy Access

Targeted therapies depend on companion diagnostics CDx to identify the right patients When those diagnostics

Rapid Method Development to Address Purification Challenges in Bispecific Antibodies

It is an emerging class of therapeutic protein that is able to bind two different targets at the same time

The Growth of Biologic Therapies

Innovation, Effectiveness, and Barriers to Access

Modern therapy is changing rapidly playing an important role in this round with biological agents